Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Home Properties Inc. ( HME - Snapshot Report ) , a multifamily real estate investment trust (REIT), has recently acquired ‘Howard Crossing’ – a 1,350-unit garden-style apartment community in Ellicott City, Maryland, for $186 million in cash. The company expects to incur an additional acquisition cost of approximately $2.2 million, which would be included as ‘other expenses’ in the operating results of the second quarter of 2012.
The purchase price equates to approximately $138,000 per apartment unit. The acquisition was partially funded by utilizing the proceeds from the issuance of $50 million worth of unsecured Senior Guaranteed Notes scheduled to mature on June 27, 2019. The remainder of the purchase price was funded through a combination of debt under the line of credit and a $100 million unsecured bank demand loan.
The apartment community has 680 one-bedroom units and 670 two-bedroom units, with the average unit size being 854 square feet. The property offers amenities such as two swimming pools, a business center, a fitness center, basketball courts and tennis courts.
The property is strategically located in close proximity to major employment centers and corporate campuses in the region. At the close of the transaction, the property was 92.6% occupied at monthly rents averaging $1,111 per unit. Home Properties further intends to spend approximately $12 million during the first three years of its ownership, in addition to normal capital expenditures, to upgrade the property.
Home Properties primarily operates along the East Coast of the U.S. The key target markets of the company include New York-Long Island/New Jersey, Boston, Washington D.C./Northern Virginia, Baltimore, Philadelphia and Chicago. The company typically invests $200 million - $300 million annually to acquire multifamily communities to fuel its growth engine.
Home Properties largely focuses on the relatively stable markets in the suburban region of major metropolitan areas that have significant barriers to new construction, a favorable supply/demand relationship, high single-family home prices, stable job growth, and reduced vulnerability to economic downturns.
We presently have a Neutral recommendation on Home Properties, which has a Zacks #3 Rank that translates into a short-term Hold rating. We also have a Neutral recommendation and a Zacks #4 Rank (short-term Sell rating) for BRE Properties Inc. ( BRE - Analyst Report ) , one of the peers of Home Properties.
Read the full reports :
Snapshot Report on HME
Analyst Report on BRE